Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shyamala Maheswaran, Ph.D.

Co-Author

This page shows the publications co-authored by Shyamala Maheswaran and Patricia Donahoe.
Connection Strength

0.907
  1. HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A. 2010 Jan 19; 107(3):1100-5.
    View in: PubMed
    Score: 0.106
  2. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism. Cancer Res. 2007 Mar 15; 67(6):2747-56.
    View in: PubMed
    Score: 0.088
  3. Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism. Mol Endocrinol. 2006 Oct; 20(10):2382-91.
    View in: PubMed
    Score: 0.083
  4. Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model. Proc Natl Acad Sci U S A. 2005 Mar 01; 102(9):3219-24.
    View in: PubMed
    Score: 0.076
  5. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications. Mol Cell Endocrinol. 2003 Dec 15; 211(1-2):37-42.
    View in: PubMed
    Score: 0.070
  6. Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26):15601-6.
    View in: PubMed
    Score: 0.070
  7. Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells. J Biol Chem. 2003 Dec 19; 278(51):51703-12.
    View in: PubMed
    Score: 0.069
  8. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):239-44.
    View in: PubMed
    Score: 0.061
  9. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev. 2001 Oct; 22(5):657-74.
    View in: PubMed
    Score: 0.060
  10. Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo. J Biol Chem. 2001 Jul 20; 276(29):26799-806.
    View in: PubMed
    Score: 0.059
  11. Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism. J Biol Chem. 2000 Nov 24; 275(47):37101-9.
    View in: PubMed
    Score: 0.057
  12. Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. J Biol Chem. 2000 Sep 15; 275(37):28371-9.
    View in: PubMed
    Score: 0.056
  13. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Clin Cancer Res. 1999 Nov; 5(11):3488-99.
    View in: PubMed
    Score: 0.053
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.